UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-33006  


MERGE HEALTHCARE INCORPORATED

(Exact name of registrant as specified in its charter)


350 North Orleans Street, 1st Floor
Chicago, Illinois 60654
(312) 565-6868

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


Common Stock, par value $0.01 per share

(Title of each class of securities covered by this Form)


None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)


Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


 
Rule 12g-4(a)(1)
 
 
Rule 12g-4(a)(2)
 
 
Rule 12h-3(b)(1)(i)
 
 
Rule 12h-3(b)(1)(ii)
 
  Rule 15d-6  
  Rule 15d-22(b)
 

 
Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, Merge Healthcare Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
  MERGE HEALTHCARE INCORPORATED  
       
Date:  October 23, 2015
By:
/s/ Justin Dearborn  
    Name:  Justin Dearborn  
    Title:    President